When Metabolically Healthy Is Not Low Risk: BMI Thresholds for Incident Diabetes in East Asian Adults.

IF 6.1 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Diabetes, Obesity & Metabolism Pub Date : 2026-11-01 Epub Date: 2026-08-17 DOI:10.1111/dom.71235
Yibo Li, Xinyi Liu, Lijing Shang, Yuhao Wang, Zhongyin Chen, Yuehang Yang, Linfeng He
{"title":"When Metabolically Healthy Is Not Low Risk: BMI Thresholds for Incident Diabetes in East Asian Adults.","authors":"Yibo Li, Xinyi Liu, Lijing Shang, Yuhao Wang, Zhongyin Chen, Yuehang Yang, Linfeng He","doi":"10.1111/dom.71235","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To determine whether metabolic health attenuates body mass index (BMI)-related risk of diabetes in East Asian adults and to identify BMI thresholds at which risk increases among metabolically healthy individuals.</p><p><strong>Materials and methods: </strong>We analysed 125 843 adults from two longitudinal cohorts, including 113 354 Chinese and 12 489 Japanese participants. Metabolic health was stringently defined as the absence of elevated blood pressure, dyslipidaemia and impaired fasting glucose. Participants were categorised by BMI and metabolic health status. Cox proportional hazards models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for incident diabetes, using metabolically healthy normal weight (MHNW) as the reference. Restricted cubic splines assessed non-linear BMI-diabetes associations by metabolic health status.</p><p><strong>Results: </strong>During 352 036 Chinese and 89 483 Japanese person-years, 1483 and 312 participants, respectively, developed diabetes. In the primary model adjusted for age, gender, smoking, and drinking, compared with MHNW, metabolically healthy overweight was associated with incident diabetes in Chinese (HR: 2.33, 95% CI: 1.63-3.33) and Japanese participants (HR: 3.32, 95% CI: 1.50-7.35). Metabolically healthy obesity (MHO) was also associated with a higher risk (Chinese: HR: 12.40, 95% CI: 6.77-22.68; Japanese: HR: 27.89, 95% CI: 8.42-92.41). The reported change points were 22.2 kg/m<sup>2</sup> in Chinese and 21.8 kg/m<sup>2</sup> in Japanese metabolically healthy participants.</p><p><strong>Conclusions: </strong>Metabolic health did not eliminate BMI-related diabetes risk in East Asian adults. Diabetes risk increased at BMI levels below conventional overweight thresholds, supporting joint assessment of BMI and metabolic health for diabetes risk stratification.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":"10227-10235"},"PeriodicalIF":6.1000,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.71235","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: To determine whether metabolic health attenuates body mass index (BMI)-related risk of diabetes in East Asian adults and to identify BMI thresholds at which risk increases among metabolically healthy individuals.

Materials and methods: We analysed 125 843 adults from two longitudinal cohorts, including 113 354 Chinese and 12 489 Japanese participants. Metabolic health was stringently defined as the absence of elevated blood pressure, dyslipidaemia and impaired fasting glucose. Participants were categorised by BMI and metabolic health status. Cox proportional hazards models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for incident diabetes, using metabolically healthy normal weight (MHNW) as the reference. Restricted cubic splines assessed non-linear BMI-diabetes associations by metabolic health status.

Results: During 352 036 Chinese and 89 483 Japanese person-years, 1483 and 312 participants, respectively, developed diabetes. In the primary model adjusted for age, gender, smoking, and drinking, compared with MHNW, metabolically healthy overweight was associated with incident diabetes in Chinese (HR: 2.33, 95% CI: 1.63-3.33) and Japanese participants (HR: 3.32, 95% CI: 1.50-7.35). Metabolically healthy obesity (MHO) was also associated with a higher risk (Chinese: HR: 12.40, 95% CI: 6.77-22.68; Japanese: HR: 27.89, 95% CI: 8.42-92.41). The reported change points were 22.2 kg/m2 in Chinese and 21.8 kg/m2 in Japanese metabolically healthy participants.

Conclusions: Metabolic health did not eliminate BMI-related diabetes risk in East Asian adults. Diabetes risk increased at BMI levels below conventional overweight thresholds, supporting joint assessment of BMI and metabolic health for diabetes risk stratification.

当代谢健康不是低风险:东亚成年人发生糖尿病的BMI阈值。
目的:确定代谢健康是否会降低东亚成年人体重指数(BMI)相关的糖尿病风险,并确定代谢健康个体的BMI阈值。材料和方法:我们分析了来自两个纵向队列的125 843名成年人,其中包括113 354名中国人和12 489名日本人。代谢健康被严格定义为没有血压升高、血脂异常和空腹血糖受损。参与者根据身体质量指数和代谢健康状况进行分类。Cox比例风险模型以代谢健康的正常体重(MHNW)为参考,估计糖尿病发生率的风险比(hr)和95%置信区间(CIs)。限制三次样条通过代谢健康状况评估bmi与糖尿病的非线性关联。结果:在352 036名中国人和89 483名日本人年中,分别有1483名和312名参与者患糖尿病。在调整了年龄、性别、吸烟和饮酒因素的初始模型中,与MHNW相比,代谢健康的超重与中国参与者(HR: 2.33, 95% CI: 1.63-3.33)和日本参与者(HR: 3.32, 95% CI: 1.50-7.35)的糖尿病发病率相关。代谢健康型肥胖(MHO)也与较高的风险相关(中国:HR: 12.40, 95% CI: 6.77-22.68;日本:HR: 27.89, 95% CI: 8.42-92.41)。报告的变化点在中国为22.2 kg/m2,在日本代谢健康的参与者为21.8 kg/m2。结论:代谢健康并不能消除东亚成年人bmi相关的糖尿病风险。BMI低于常规超重阈值时,糖尿病风险增加,支持BMI和代谢健康对糖尿病风险分层的联合评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书